PROCAM Based Myocardial Infarction Risk in Relation to Global Vascular Disease Risk: Observations from the ARCO Cohort Study. Swiss Med Wkly 2022, 152 (0708), w30111. https://doi.org/10.4414/SMW.2022.w30111.